Skip to main content

Table 3 Incremental differences in annual healthcare utilization and costs between the RSV patients and the matched controls over the follow-up period

From: Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis

 

1 year

2–4 years

5–17 years

18–49 years

50–64 years

65–74 years

75–84 years

≥85 years

Inpatient visit

  ≥ 1 visit, (%)

10.6

11

7.7

6.2

9.9

22.8

23.1

28.5

 No. of visits, mean

0.2

0.2

0.2

0.1

0.2

0.5

0.6

0.5

 Length of stay (days), mean

0.4

0.3

0.7

0.4

0.8

2.9

3.0

1.9

 Inpatient costs, mean

$1345

$1637

$3855

$2384

$2913

$6453

$11,383

$2993

ED/UC

  ≥ 1 visit, (%)

20.4

19.9

15.2

17.9

19.2

22.8

22.1

26.6

 No. of visits, mean

0.2

0.3

0.2

0.2

0.2

0.4

0.5

0.4

 ED/UC costs, mean

$491

$440

$467

$601

$826

$658

$720

$713

Ambulatory visit

  ≥ 1 visit, (%)

20.3

18.3

15.1

12.2

7.0

12.6

12.8

12.3

 No. of visits, mean

0.7

0.8

1.2

1.0

1.4

2.2

2.7

0.7

 Ambulatory costs, mean

$713

$732

$1780

$1525

$2174

$1597

$1014

$3849

Outpatient visit

  ≥ 1 visit, (%)

3.6

4.8

13.4

16.4

8.4

5.5

5.9

6.8

 No. of visits, mean

5.0

4.7

6.2

5.5

7.9

12.1

18.1

18.6

 Outpatient costs, mean

$839

$849

$1824

$1194

$1595

$4320

$11,785

$8398

Prescriptions filled

  ≥ 1 prescription, (%)

22.5

23.5

30.6

17.7

10.4

4.7

0.7

0.4

 No. of prescriptions, mean

3.1

3.4

4.3

4.3

7.5

10.0

9.5

14.6

 Prescription costs, mean

$285

$515

$870

$1127

$1246

$2022

$1249

$800

Total unadjusted costs,a mean

$3673

$4173

$8796

$6832

$8753

$15,050

$26,151

$16,752

  1. ED: emergency department, RSV: respiratory syncytial virus, UC: urgent care
  2. Costs adjusted to 2014 US dollars
  3. aTotal unadjusted costs are the sum of the costs from the individual resource categories